Genmab A/S registered a share capital reduction of DKK 1,900,000 by cancelling 1,900,000 treasury shares, resulting in total share capital of DKK 62,350,721 comprising 62,350,721 shares and votes.
Key takeaways
Annual General Meeting on March 19, 2026 approved reduction of share capital by DKK 1,900,000 via cancellation of 1,900,000 shares of DKK 1 each.
Reduction registered with Danish Business Authority on April 17, 2026.
Nasdaq system update expected on April 21, 2026.
Post-reduction share capital totals DKK 62,350,721 with 62,350,721 shares and votes.
Reduces outstanding shares, potentially increasing EPS without changing economic ownership.